Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC
UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1900p (from 1950p).
Broker Forecasts data provided by...
Tue, 11/02/2020 - 10:30